HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Bahamondes Selected Research

Levonorgestrel (Plan B)

2/2024Gene expression associated with vaginal bleeding in women using the 52-mg levonorgestrel hormonal intrauterine device: A prospective study.
1/2024Uptake, discontinuation, and continuation rate of long-acting contraceptive methods (LARC) when offered at no cost in Campinas, Brazil.
12/2023Clinical Assessment of 3 Intrauterine Devices in Adolescent Girls: A Randomized Clinical Trial.
6/2023Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery.
1/2023Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
1/2022Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
1/2021Association between breast cancer risk and levonorgestrel-releasing intrauterine system.
12/2020Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy.
10/2020Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women.
4/2020A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52-mg levonorgestrel intrauterine system.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis Bahamondes Research Topics

Disease

24Hemorrhage
01/2024 - 01/2002
20Pain (Aches)
12/2023 - 04/2005
13Endometriosis
04/2020 - 07/2005
11Pelvic Pain
04/2020 - 04/2005
10Amenorrhea
12/2023 - 10/2007
9COVID-19
03/2024 - 06/2020
9Menorrhagia
01/2022 - 05/2002
6Dysmenorrhea (Menstrual Pain)
12/2023 - 06/2007
5Uterine Hemorrhage (Uterine Bleeding)
02/2024 - 07/2006
4Insulin Resistance
06/2018 - 04/2015
4Weight Gain
11/2016 - 07/2003
3Metrorrhagia (Spotting)
01/2024 - 06/2006
3Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2022 - 10/2018
3Infections
12/2021 - 08/2003
3Neoplasms (Cancer)
10/2018 - 07/2007
3Body Weight (Weight, Body)
11/2016 - 10/2012
3Adenomyosis
09/2015 - 06/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 09/2015
2Breast Neoplasms (Breast Cancer)
01/2021 - 01/2020
2Endometrial Hyperplasia
09/2015 - 06/2003
2Leiomyoma (Uterine Fibroids)
09/2015 - 07/2008
2Maternal Death
10/2014 - 01/2014
2Bacterial Vaginosis
07/2011 - 08/2003
1Premature Birth (Birth, Premature)
01/2023
1Meningioma (Meningiomas)
10/2022
1Endometrial Neoplasms (Endometrial Cancer)
08/2022
1Erythema Nodosum
01/2022
1Leprosy (Hansen's Disease)
01/2022
1Thrombosis (Thrombus)
12/2020
1Oligomenorrhea
12/2020
1Thromboembolism
06/2020
1Rupture
01/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019
1Atrophy
12/2018
1Cardiovascular Diseases (Cardiovascular Disease)
06/2018
1Pelvic Infection
01/2018
1Thrombophilia
06/2017
1Bulimia (Binge Eating)
11/2016
1Binge-Eating Disorder (Binge Eating Disorder)
11/2016

Drug/Important Bio-Agent (IBA)

39Contraceptive Agents (Contraceptives)IBA
02/2024 - 05/2006
35Levonorgestrel (Plan B)FDA LinkGeneric
02/2024 - 01/2002
11N,N-dimethyl-4-anisidine (DMPA)IBA
08/2022 - 10/2007
10etonogestrel (Implanon)FDA Link
01/2024 - 05/2006
8Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric
06/2018 - 02/2010
56-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
09/2011 - 04/2005
4CopperIBA
06/2023 - 07/2003
3Lidocaine (Xylocaine)FDA LinkGeneric
10/2020 - 12/2019
3Progestins (Progestagens)IBA
04/2020 - 03/2011
3Biomarkers (Surrogate Marker)IBA
04/2020 - 11/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2016 - 04/2015
2Combined Oral ContraceptivesIBA
09/2015 - 04/2012
2Estrogens (Estrogen)FDA Link
05/2012 - 07/2008
2Metronidazole (Metric)FDA LinkGeneric
07/2011 - 09/2008
2Matrix Metalloproteinases (MMPs)IBA
06/2006 - 08/2004
1VaccinesIBA
03/2024
1COVID-19 VaccinesIBA
10/2023
1ORALIT (ORS)IBA
01/2023
1nomegestrolIBA
10/2022
1Chlormadinone Acetate (Chlormadinone)IBA
10/2022
1Oral ContraceptivesIBA
10/2022
1Hormones (Hormone)IBA
04/2022
1Thalidomide (Thalomid)FDA Link
01/2022
1Vitamin DFDA LinkGeneric
12/2021
1AnticoagulantsIBA
12/2020
1ulipristal acetateFDA Link
04/2020
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
01/2020
1mesoglycanIBA
01/2020
1salicylhydroxamic acid (SHAM)IBA
01/2020
1segesterone acetate and ethinyl estradiol vaginal systemIBA
12/2019
1Ethinyl Estradiol (Estinyl)FDA LinkGeneric
12/2019
1KetorolacIBA
12/2019
1Macular PigmentIBA
12/2018
1AntigensIBA
10/2018
1Anti-Infective Agents (Microbicides)IBA
10/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1fibrin fragment D (D-dimer)IBA
06/2017
1ThrombinFDA Link
06/2017
1Neuropeptide YIBA
11/2016
1BESIBA
11/2016
1AdiponectinIBA
11/2016
1CGS 24012 (DPMA)IBA
11/2016
1LeptinIBA
11/2016

Therapy/Procedure

19Contraception (Birth Control)
02/2024 - 01/2005
7Intrauterine Devices (Intrauterine Device)
02/2024 - 08/2003
5Therapeutics
08/2016 - 05/2002
4Hysterectomy
01/2022 - 05/2002
3Pain Management
06/2023 - 12/2016
3Copper Intrauterine Devices
09/2015 - 08/2014
2Anesthesia
10/2020 - 09/2012
2Injections
01/2016 - 08/2015
1Vasectomy (Vas Occlusion)
01/2022
1Tubal Sterilization (Tubal Ligation)
01/2022
1Postnatal Care
01/2021
1Prenatal Care (Care, Prenatal)
01/2021
1Device Removal (Removal, Device)
04/2020
1Aftercare (After-Treatment)
04/2020
1Obstetrical Anesthesia
01/2020
1Analgesia
12/2019
1Experimental Implants
11/2018